Literature DB >> 3531287

Real-time Doppler color flow mapping for detection of patent ductus arteriosus.

R E Swensson, L M Valdes-Cruz, D J Sahn, F S Sherman, K J Chung, S Scagnelli, S Hagen-Ansert.   

Abstract

In this study, ultrasound Doppler color flow mapping systems were utilized to examine flow in the pulmonary artery in 31 premature and term infants (aged 4 hours to 9 months) with patent ductus arteriosus accompanying respiratory distress syndrome, as an isolated lesion, or with patent ductus in association with other cyanotic or acyanotic congenital heart disorders. The flow mapping patterns were compared with those of a control population of 15 infants who did not have patent ductus arteriosus. In unconstricted ductus arteriosus, the flow from the aorta into the pulmonary artery was detected in late systole and early diastole and was distributed along the superior leftward lateral wall of the main pulmonary artery from the origin of the left pulmonary artery back in a proximal direction toward the pulmonary valve. In constricted patent ductus arteriosus, or especially in a ductus in association with cyanotic heart disease, the position of the ductal shunt in the pulmonary artery was more variable, often directed centrally or medially. Waveform spectral Doppler sampling could be performed in specific positions guided by the Doppler flow map to verify the phasic characteristics of the ductal shunt on spectral and audio outputs. Shunts through a very small patent ductus arteriosus were routinely detected in this group of infants, and right to left ductal shunts could also be verified by the Doppler flow mapping technique. This study suggests substantial promise for real-time two-dimensional Doppler echocardiographic flow mapping for evaluation of patent ductus arteriosus in infants.

Entities:  

Mesh:

Year:  1986        PMID: 3531287     DOI: 10.1016/s0735-1097(86)80388-6

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  14 in total

Review 1.  [Echocardiographic evaluation in unoperated congenital heart disease in adults].

Authors:  A Geibel
Journal:  Herz       Date:  1999-06       Impact factor: 1.443

Review 2.  Echocardiography in adult congenital heart disease.

Authors:  A Houston; S Hillis; S Lilley; T Richens; L Swan
Journal:  Heart       Date:  1998-11       Impact factor: 5.994

3.  Doppler flow characteristics in the assessment of pulmonary artery pressure in ductus arteriosus.

Authors:  A B Houston; M K Lim; W B Doig; J Gnanapragasam; E N Coleman; M P Jamieson; J C Pollock
Journal:  Br Heart J       Date:  1989-10

4.  Stepwise evaluation of left to right shunts by echocardiography.

Authors:  Neeraj Awasthy; S Radhakrishnan
Journal:  Indian Heart J       Date:  2013-03-21

5.  COLOUR DOPPLER ECHOCARDIOGRAPHY IN THE MANAGEMENT OF CONGENITAL HEART DISEASE.

Authors:  V Vatwani; R Ghuliani
Journal:  Med J Armed Forces India       Date:  2017-06-27

Review 6.  Echocardiography in the diagnosis of thoracic aortic pathology.

Authors:  F D Tice; J Kisslo
Journal:  Int J Card Imaging       Date:  1993

7.  Does endothelin-1 reduce superior mesenteric artery blood flow velocity in preterm neonates?

Authors:  F J Weir; A Ohlsson; K Fong; K Amankwah; F Coceani
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-03       Impact factor: 5.747

8.  Variation in the diagnosis and management of patent ductus arteriosus in premature infants.

Authors:  L S Lai; B W McCrindle
Journal:  Paediatr Child Health       Date:  1998-11       Impact factor: 2.253

9.  Prediction of ductus arteriosus closure by neonatal screening echocardiography.

Authors:  Sheng-Ling Jan; Betau Hwang; Yun-Ching Fu; Ching-Shiang Chi
Journal:  Int J Cardiovasc Imaging       Date:  2004-08       Impact factor: 2.357

10.  The effect of dexamethasone on time averaged mean velocity in the middle cerebral artery in very low birth weight infants.

Authors:  A Ohlsson; J Bottu; J Govan; M L Ryan; T Myhr; K Fong
Journal:  Eur J Pediatr       Date:  1994-05       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.